Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

GH-releasing peptides from Novo Nordisk

Feb. 25, 1997

Novo Nordisk's growth hormone now available in 67 countries

Feb. 24, 1997

Merck's Fosamax earns recommendation

Feb. 24, 1997

SKB prepares chimeric leptins

Feb. 20, 1997

Indian investigators prepare novel hypolipidemic agents

Feb. 20, 1997

New ACAT inhibitor associated with diarrhea

Feb. 19, 1997

First launch for lipid-lowering statin

Feb. 19, 1997

Japanese introduction for new formulation of epoetin alfa

Feb. 18, 1997

Human Genome Sciences describes MCP-4 polypeptide

Feb. 14, 1997

EPO activators/agonists described by J&J and Affymax

Feb. 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...